(Q43971537)

28 November 2017

title

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against (English)

1 reference

28 November 2017

1 reference

Kirk A Frey

1

1 reference

28 November 2017

publication date

22 March 2002

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

28 November 2017

published in

1 reference

28 November 2017

volume

29

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

715-717

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-002-0815-4

28 November 2017

exact match

0 references

cites work

Dopa decarboxylase activity of the living human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11976814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of dopaminergic activity in early Parkinson's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11976814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-002-0815-4

1 reference

28 November 2017

1 reference